TipRanks
Go Ultimate55% OFF

ABL Bio, Inc. (298380) Price & Analysis

298380 Stock Chart & Stats

₩39,200.00-₩1,800.00(-4.39%)
At close: 4:00 PM EDT
KRW 40,000KRW 60,000KRW 80,0003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
KRW 38,250.00 - KRW 40,800.00
52-Week Range
KRW 38,250.00 - KRW 257,500.00
Previous Close
KRW 41,000.00
Volume
N/A
Average Volume (3M)
291.71K
Market Cap
KRW 2.19T
Enterprise Value
KRW 5.46T
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
―
Beta
0.34
Next Earnings
Nov 17, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

298380 FAQ

What was ABL Bio, Inc.’s price range in the past 12 months?
ABL Bio, Inc. lowest stock price was ₩38250.00 and its highest was ₩257500.00 in the past 12 months.
What is ABL Bio, Inc.’s market cap?
ABL Bio, Inc.’s market cap is ₩2.19T.
When is ABL Bio, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ABL Bio, Inc.’s earnings last quarter?
ABL Bio, Inc. released its earnings results on Aug 11, 2026. The company reported -₩262.897 earnings per share for the quarter.
Is ABL Bio, Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does ABL Bio, Inc. pay dividends?
ABL Bio, Inc. does not currently pay dividends.
What is ABL Bio, Inc.’s EPS estimate?
ABL Bio, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ABL Bio, Inc. have?
ABL Bio, Inc. has 55,987,465 shares outstanding.
What happened to ABL Bio, Inc.’s price movement after its last earnings report?
ABL Bio, Inc. reported an EPS of -₩262.897 in its last earnings report. Following the earnings report the stock price went down -4.808%.
Which hedge fund is a major shareholder of ABL Bio, Inc.?
Currently, no hedge funds are holding shares in KR:298380
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology